Anavex Life Sciences Corp (AVXL)

[Talon38]

Biogen's Lab - Take a look below from Biogen's website and see the scientists and the lab where the ANAVEX/BIOGEN MTA for 2-73 is being accomplished. Listen to Biogen's research leaders as the discuss their goal for remyelinaion and translating the the successes in M/S to other neurodegenerative diseases. WOW Looks like a dedicated bunch and a good place for our drug to be investigated.

Think of their input to Michel Vounatsos on what they have seen in the lab and the science research on the Sigma 1 platform. And the talk Vounatsos has with his Board about a platform of ANAVEX drugs that may have effectiveness over the broad sweep of major CNS diseases : Alzheimer'a, M/S, ALS, Frontal Lobe Dementia, Parkinson's ,Epilepsy, Rest Syndrome, Fragile X, Angelman's and TBI. The question posed is..... Can Biogen compete against these drugs in the future let alone continue its quest to be the leading neuroscience company in the world.....so then what must be offered to secure Biogen's future.

Dr Chris Missling's goal is to not only secure ANAVEX financially through the next 2 to 3 years of the pipeline development but also keep a secure hold of a rapidly increasing revenue stream through the decades to come .

I think this will be facilitated by Janet Woodcock approaching Scott Gottlieb with her first CNS candidate for FDA's stated goal of..."Helping create clinical trial networks and "master protocols," where appropriate to greatly reduce the cost of conducting clinical trials and reduce the time needed to carry them out"

----

https://www.biogen.com/en_us/about-biogen/multiple-sclerosis/leading_a-path-forward.leading-way-ms.html